146 related articles for article (PubMed ID: 38423021)
1. Effect of BCG vaccination against Mycobacterium tuberculosis infection in adult Brazilian health-care workers: a nested clinical trial.
Dos Santos PCP; Messina NL; de Oliveira RD; da Silva PV; Puga MAM; Dalcolmo M; Dos Santos G; de Lacerda MVG; Jardim BA; de Almeida E Val FF; Curtis N; Andrews JR; Croda J
Lancet Infect Dis; 2024 Jun; 24(6):594-601. PubMed ID: 38423021
[TBL] [Abstract][Full Text] [Related]
2. Bacillus Calmette-Guérin vaccination for protection against recurrent herpes labialis: a nested randomised controlled trial.
Pittet LF; Moore CL; McDonald E; Barry S; Bonten M; Campbell J; Croda J; Dalcolmo M; Davidson A; Douglas MW; Gardiner K; Gwee A; Jardim B; Lacerda MVG; Lucas M; Lynn DJ; Manning L; de Oliveira RD; Perrett KP; Prat-Aymerich C; Richmond PC; Rocha JL; Rodriguez-Baño J; Warris A; Wood NJ; Messina NL; Curtis N;
EClinicalMedicine; 2023 Oct; 64():102203. PubMed ID: 37719417
[TBL] [Abstract][Full Text] [Related]
3. Bacille Calmette-Guérin vaccination to prevent febrile and respiratory illness in adults (BRACE): secondary outcomes of a randomised controlled phase 3 trial.
Pittet LF; Messina NL; McDonald E; Orsini F; Barry S; Bonten M; Campbell J; Croda J; Croda MG; Dalcolmo M; Gardiner K; Gwee A; Jardim B; Lacerda MVG; Lucas M; Lynn DJ; Manning L; Perrett KP; Post JJ; Prat-Aymerich C; Richmond PC; Rocha JL; Rodriguez-Baño J; Warris A; Wood NJ; Davidson A; Curtis N;
EClinicalMedicine; 2024 Jun; 72():102616. PubMed ID: 38774675
[TBL] [Abstract][Full Text] [Related]
4. Comparison of interferon-γ release assay to two cut-off points of tuberculin skin test to detect latent Mycobacterium tuberculosis infection in primary health care workers.
de Souza FM; do Prado TN; Pinheiro Jdos S; Peres RL; Lacerda TC; Loureiro RB; Carvalho JA; Fregona G; Dias ES; Cosme LB; Rodrigues RR; Riley LW; Maciel EL
PLoS One; 2014; 9(8):e102773. PubMed ID: 25137040
[TBL] [Abstract][Full Text] [Related]
5. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.
Madsen AMR; Schaltz-Buchholzer F; Benfield T; Bjerregaard-Andersen M; Dalgaard LS; Dam C; Ditlev SB; Faizi G; Johansen IS; Kofoed PE; Kristensen GS; Loekkegaard ECL; Mogensen CB; Mohamed L; Ostenfeld A; Oedegaard ES; Soerensen MK; Wejse C; Jensen AKG; Nielsen S; Krause TG; Netea MG; Aaby P; Benn CS
Trials; 2020 Sep; 21(1):799. PubMed ID: 32943115
[TBL] [Abstract][Full Text] [Related]
6. Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination.
Nemes E; Geldenhuys H; Rozot V; Rutkowski KT; Ratangee F; Bilek N; Mabwe S; Makhethe L; Erasmus M; Toefy A; Mulenga H; Hanekom WA; Self SG; Bekker LG; Ryall R; Gurunathan S; DiazGranados CA; Andersen P; Kromann I; Evans T; Ellis RD; Landry B; Hokey DA; Hopkins R; Ginsberg AM; Scriba TJ; Hatherill M;
N Engl J Med; 2018 Jul; 379(2):138-149. PubMed ID: 29996082
[TBL] [Abstract][Full Text] [Related]
7. Live-attenuated Mycobacterium tuberculosis vaccine MTBVAC versus BCG in adults and neonates: a randomised controlled, double-blind dose-escalation trial.
Tameris M; Mearns H; Penn-Nicholson A; Gregg Y; Bilek N; Mabwe S; Geldenhuys H; Shenje J; Luabeya AKK; Murillo I; Doce J; Aguilo N; Marinova D; Puentes E; Rodríguez E; Gonzalo-Asensio J; Fritzell B; Thole J; Martin C; Scriba TJ; Hatherill M;
Lancet Respir Med; 2019 Sep; 7(9):757-770. PubMed ID: 31416768
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of the C-Tb skin test to diagnose Mycobacterium tuberculosis infection, compared with an interferon γ release assay and the tuberculin skin test: a phase 3, double-blind, randomised, controlled trial.
Ruhwald M; Aggerbeck H; Gallardo RV; Hoff ST; Villate JI; Borregaard B; Martinez JA; Kromann I; Penas A; Anibarro LL; de Souza-Galvão ML; Sánchez F; Rodrigo-Pendás JÁ; Noguera-Julian A; Martínez-Lacasa X; Tuñez MV; Fernández VL; Millet JP; Moreno A; Cobos N; Miró JM; Roldan L; Orcau A; Andersen P; Caylá JA;
Lancet Respir Med; 2017 Apr; 5(4):259-268. PubMed ID: 28159608
[TBL] [Abstract][Full Text] [Related]
9. Safety and immunogenicity of the novel tuberculosis vaccine ID93 + GLA-SE in BCG-vaccinated healthy adults in South Africa: a randomised, double-blind, placebo-controlled phase 1 trial.
Penn-Nicholson A; Tameris M; Smit E; Day TA; Musvosvi M; Jayashankar L; Vergara J; Mabwe S; Bilek N; Geldenhuys H; Luabeya AK; Ellis R; Ginsberg AM; Hanekom WA; Reed SG; Coler RN; Scriba TJ; Hatherill M;
Lancet Respir Med; 2018 Apr; 6(4):287-298. PubMed ID: 29595510
[TBL] [Abstract][Full Text] [Related]
10. Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trial.
Ndiaye BP; Thienemann F; Ota M; Landry BS; Camara M; Dièye S; Dieye TN; Esmail H; Goliath R; Huygen K; January V; Ndiaye I; Oni T; Raine M; Romano M; Satti I; Sutton S; Thiam A; Wilkinson KA; Mboup S; Wilkinson RJ; McShane H;
Lancet Respir Med; 2015 Mar; 3(3):190-200. PubMed ID: 25726088
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the interferon- gamma release assay and the tuberculin skin test for contact investigation of tuberculosis in BCG-vaccinated health care workers.
Lee SS; Liu YC; Huang TS; Chen YS; Tsai HC; Wann SR; Lin HH
Scand J Infect Dis; 2008; 40(5):373-80. PubMed ID: 18418798
[TBL] [Abstract][Full Text] [Related]
12. Safety of a controlled human infection model of tuberculosis with aerosolised, live-attenuated Mycobacterium bovis BCG versus intradermal BCG in BCG-naive adults in the UK: a dose-escalation, randomised, controlled, phase 1 trial.
Satti I; Marshall JL; Harris SA; Wittenberg R; Tanner R; Lopez Ramon R; Wilkie M; Ramos Lopez F; Riste M; Wright D; Peralta Alvarez MP; Williams N; Morrison H; Stylianou E; Folegatti P; Jenkin D; Vermaak S; Rask L; Cabrera Puig I; Powell Doherty R; Lawrie A; Moss P; Hinks T; Bettinson H; McShane H
Lancet Infect Dis; 2024 Apr; ():. PubMed ID: 38621405
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness and cost-effectiveness of first BCG vaccination against tuberculosis in school-age children without previous tuberculin test (BCG-REVAC trial): a cluster-randomised trial.
Pereira SM; Barreto ML; Pilger D; Cruz AA; Sant'Anna C; Hijjar MA; Ichihara MY; Santos AC; Genser B; Rodrigues LC
Lancet Infect Dis; 2012 Apr; 12(4):300-6. PubMed ID: 22071248
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of latent tuberculosis infection in healthy young adults in a country with high tuberculosis burden and BCG vaccination at birth.
Dagnew AF; Hussein J; Abebe M; Zewdie M; Mihret A; Bedru A; Chanyalew M; Yamuah L; Medhin G; Bang P; Doherty TM; Hailu A; Aseffa A
BMC Res Notes; 2012 Aug; 5():415. PubMed ID: 22870897
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube Interferon Gamma Release Assays in Patients at Risk for Tuberculosis and in Health Care Workers.
Theel ES; Hilgart H; Breen-Lyles M; McCoy K; Flury R; Breeher LE; Wilson J; Sia IG; Whitaker JA; Clain J; Aksamit TR; Escalante P
J Clin Microbiol; 2018 Jul; 56(7):. PubMed ID: 29743310
[TBL] [Abstract][Full Text] [Related]
16. Serial QuantiFERON testing and tuberculosis disease risk among young children: an observational cohort study.
Andrews JR; Nemes E; Tameris M; Landry BS; Mahomed H; McClain JB; Fletcher HA; Hanekom WA; Wood R; McShane H; Scriba TJ; Hatherill M
Lancet Respir Med; 2017 Apr; 5(4):282-290. PubMed ID: 28215501
[TBL] [Abstract][Full Text] [Related]
17. BCG revaccination of health workers in Brazil to improve innate immune responses against COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Junqueira-Kipnis AP; Dos Anjos LRB; Barbosa LCS; da Costa AC; Borges KCM; Cardoso ADRO; Ribeiro KM; Rosa SBA; Souza CC; das Neves RC; Saraiva G; da Silva SM; Silveira EA; Rabahi MF; Conte MB; Kipnis A
Trials; 2020 Oct; 21(1):881. PubMed ID: 33106170
[TBL] [Abstract][Full Text] [Related]
18. Screening for Mycobacterium tuberculosis infection among healthcare workers in New Zealand: prospective comparison between the tuberculin skin test and the QuantiFERON-TB Gold In-Tube assay.
Freeman JT; Marshall RJ; Newton S; Austin P; Taylor S; Chew TC; Gavaghan S; Roberts SA
N Z Med J; 2012 Feb; 125(1349):21-9. PubMed ID: 22327155
[TBL] [Abstract][Full Text] [Related]
19. Immunosurveillance for Mycobacterium tuberculosis of health care personnel in a third level care hospital.
Larcher C; Frizzera E; Pretto P; Lang M; Sonnleitner N; Huemer HP
Med Lav; 2012; 103(1):26-36. PubMed ID: 22486073
[TBL] [Abstract][Full Text] [Related]
20. QuantiFERON®-TB Gold In-Tube for contact screening in BCG-vaccinated adults: A longitudinal cohort study.
Muñoz L; Gonzalez L; Soldevila L; Dorca J; Alcaide F; Santin M
PLoS One; 2017; 12(8):e0183258. PubMed ID: 28854216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
